Literature DB >> 19515767

Role of cholesterol pathways in norovirus replication.

Kyeong-Ok Chang1.   

Abstract

Norwalk virus (NV) is a prototype strain of the noroviruses (family Caliciviridae) that have emerged as major causes of acute gastroenteritis worldwide. I have developed NV replicon systems using reporter proteins such as a neomycin-resistant protein (NV replicon-bearing cells) and a green fluorescent protein (pNV-GFP) and demonstrated that these systems were excellent tools to study virus replication in cell culture. In the present study, I first performed DNA microarray analysis of the replicon-bearing cells to identify cellular factors associated with NV replication. The analysis demonstrated that genes in lipid (cholesterol) or carbohydrate metabolic pathways were significantly (P < 0.001) changed by the gene ontology analysis. Among genes in the cholesterol pathways, I found that mRNA levels of hydroxymethylglutaryl-coenzyme A (HMG-CoA) synthase, squalene epoxidase, and acyl-CoA:cholesterol acyltransferase (ACAT), ACAT2, small heterodimer partner, and low-density lipoprotein receptor (LDLR)-related proteins were significantly changed in the cells. I also found that the inhibition of cholesterol biosynthesis using statins (an HMG-CoA reductase inhibitor) significantly increased the levels of NV proteins and RNA, whereas inhibitors of ACAT significantly reduced the replication of NV in replicon-bearing cells. Up- or downregulation of virus replication with these agents significantly correlated with the mRNA level of LDLR in replicon-bearing cells. Finally, I found that the expression of LDLR promoted NV replication in trans by transfection study with pNV-GFP. I conclude that the cholesterol pathways such as LDLR expression and ACAT activity may be crucial in the replication of noroviruses in cells, which may provide potential therapeutic targets for viral infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19515767      PMCID: PMC2738148          DOI: 10.1128/JVI.00005-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository.

Authors:  Ron Edgar; Michael Domrachev; Alex E Lash
Journal:  Nucleic Acids Res       Date:  2002-01-01       Impact factor: 16.971

2.  Broadly reactive and highly sensitive assay for Norwalk-like viruses based on real-time quantitative reverse transcription-PCR.

Authors:  Tsutomu Kageyama; Shigeyuki Kojima; Michiyo Shinohara; Kazue Uchida; Shuetsu Fukushi; Fuminori B Hoshino; Naokazu Takeda; Kazuhiko Katayama
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

3.  A natural product that lowers cholesterol as an antagonist ligand for FXR.

Authors:  Nancy L Urizar; Amy B Liverman; D'Nette T Dodds; Frank Valentin Silva; Peter Ordentlich; Yingzhuo Yan; Frank J Gonzalez; Richard A Heyman; David J Mangelsdorf; David D Moore
Journal:  Science       Date:  2002-05-02       Impact factor: 47.728

Review 4.  The role of the enterohepatic circulation of bile salts and nuclear hormone receptors in the regulation of cholesterol homeostasis: Bile salts as ligands for nuclear hormone receptors.

Authors:  Richard N Redinger
Journal:  Can J Gastroenterol       Date:  2003-04       Impact factor: 3.522

Review 5.  Human cholesterol metabolism and therapeutic molecules.

Authors:  V Charlton-Menys; P N Durrington
Journal:  Exp Physiol       Date:  2008-01       Impact factor: 2.969

Review 6.  The coming of age of our understanding of the enterohepatic circulation of bile salts.

Authors:  Richard N Redinger
Journal:  Am J Surg       Date:  2003-02       Impact factor: 2.565

Review 7.  Mevalonate pathway: a review of clinical and therapeutical implications.

Authors:  Irina Buhaescu; Hassane Izzedine
Journal:  Clin Biochem       Date:  2007-03-31       Impact factor: 3.281

8.  Leader of the capsid protein in feline calicivirus promotes replication of Norwalk virus in cell culture.

Authors:  Kyeong-Ok Chang; David W George; John B Patton; Kim Y Green; Stanislav V Sosnovtsev
Journal:  J Virol       Date:  2008-07-16       Impact factor: 5.103

9.  Cell-culture propagation of porcine enteric calicivirus mediated by intestinal contents is dependent on the cyclic AMP signaling pathway.

Authors:  Kyeong-Ok Chang; Yunjeong Kim; Kim Y Green; Linda J Saif
Journal:  Virology       Date:  2002-12-20       Impact factor: 3.616

10.  Bile acids promote the expression of hepatitis C virus in replicon-harboring cells.

Authors:  Kyeong-Ok Chang; David W George
Journal:  J Virol       Date:  2007-07-03       Impact factor: 5.103

View more
  46 in total

1.  Inhibitory effects of bile acids and synthetic farnesoid X receptor agonists on rotavirus replication.

Authors:  Yunjeong Kim; Kyeong-Ok Chang
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

2.  Cyclosulfamide-based derivatives as inhibitors of noroviruses.

Authors:  Dengfeng Dou; Sivakoteswara R Mandadapu; Kevin R Alliston; Yunjeong Kim; Kyeong-Ok Chang; William C Groutas
Journal:  Eur J Med Chem       Date:  2011-10-20       Impact factor: 6.514

3.  Comparative Transcriptomic Response of Primary and Immortalized Macrophages to Murine Norovirus Infection.

Authors:  Eric A Levenson; Craig Martens; Kishore Kanakabandi; Charles V Turner; Kimmo Virtaneva; Monica Paneru; Stacy Ricklefs; Stanislav V Sosnovtsev; Jordan A Johnson; Stephen F Porcella; Kim Y Green
Journal:  J Immunol       Date:  2018-05-07       Impact factor: 5.422

4.  Median infectious dose of human norovirus GII.4 in gnotobiotic pigs is decreased by simvastatin treatment and increased by age.

Authors:  Tammy Bui; Jacob Kocher; Yanru Li; Ke Wen; Guohua Li; Fangning Liu; Xingdong Yang; Tanya LeRoith; Ming Tan; Ming Xia; Weiming Zhong; Xi Jiang; Lijuan Yuan
Journal:  J Gen Virol       Date:  2013-06-26       Impact factor: 3.891

5.  Murine Norovirus Infection Variably Alters Atherosclerosis in Mice Lacking Apolipoprotein E.

Authors:  Charlie C Hsu; Jisun Paik; Thea L Brabb; Kevin D O'Brien; Jinkyu Kim; Brittany G Sullivan; Kelly L Hudkins; Audrey Seamons; Jennifer C Finley; Stacey M Meeker; Lillian Maggio-Price
Journal:  Comp Med       Date:  2015-10       Impact factor: 0.982

Review 6.  Advances in norovirus biology.

Authors:  Stephanie M Karst; Christiane E Wobus; Ian G Goodfellow; Kim Y Green; Herbert W Virgin
Journal:  Cell Host Microbe       Date:  2014-06-11       Impact factor: 21.023

Review 7.  Current tools for norovirus drug discovery.

Authors:  Sahani Weerasekara; Allan M Prior; Duy H Hua
Journal:  Expert Opin Drug Discov       Date:  2016-05-02       Impact factor: 6.098

Review 8.  Treatment of norovirus infections: moving antivirals from the bench to the bedside.

Authors:  Stuart S Kaufman; Kim Y Green; Brent E Korba
Journal:  Antiviral Res       Date:  2014-02-25       Impact factor: 5.970

9.  Inhibition of sterol biosynthesis reduces tombusvirus replication in yeast and plants.

Authors:  Monika Sharma; Zsuzsanna Sasvari; Peter D Nagy
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

Review 10.  Recent Advances in the Discovery of Norovirus Therapeutics.

Authors:  Yunjeong Kim; Anushka C Galasiti Kankanamalage; Kyeong-Ok Chang; William C Groutas
Journal:  J Med Chem       Date:  2015-08-17       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.